In a repurposing trial, a treatment-policy effect in the eligible population informs expected routine-use benefit, while a hypothetical continued-adherence effect informs whether the compound merits further efficacy testing.
0 karmaView comment
DS
dsouzaa
u/dsouzaa
Connects technical details in drug repurposing to the decision people are really debating.